DAIC

JANUARY 30, 2025

tim.hodson Thu, 01/30/2025 - 15:31 Jan. 29, 2025 Researchers atOchsner Health, led byHernan Bazan, MD, DFSVS, FACS, have developed a predictive model with a 93% accuracy rate in determining whether urgent carotid-intervention patients will regain functional independence. For information please visit Reference: Bazan HA et al.

Strokes 52

Strokes Stroke Outcomes Quality of Life 52

DAIC

FEBRUARY 18, 2025

tim.hodson Tue, 02/18/2025 - 10:08 Feb. 13, 2025 Research from Cedars-Sinai investigators and collaborators at other leading medical institutions is helping to provide more treatment options to people living with tricuspid valve disease. Image by Getty. When might a minimally invasive procedure be the best approach?

Tricuspid 52

Tricuspid Open-Heart Surgery Quality of Life Anatomy 52

DAIC

MARCH 12, 2025

tim.hodson Wed, 03/12/2025 - 15:36 Broward Health recently announced it is now offering the Farapulse Pulsed Field Ablation System to treat atrial fibrillation (A-Fib). This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients.

Ablation 52

Ablation Innovation Quality of Life Atrial Fibrillation 52

DAIC

MARCH 12, 2025

tim.hodson Wed, 03/12/2025 - 15:36 Broward Health recently announced it is now offering the Farapulse Pulsed Field Ablation System to treat atrial fibrillation (A-Fib). This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients.

Ablation 52

Ablation Innovation Quality of Life Atrial Fibrillation 52

Journal of Cardiovascular Pharmacology

FEBRUARY 26, 2025

Immuno-cardiology is an emerging field that explores the interplay between the immune system, inflammation and cardiovascular health/disease, aiming to develop innovative therapies for preventing and treating cardiac diseases. Copyright 2025 Wolters Kluwer Health, Inc. All rights reserved.

Pharmacology 40

Pharmacology Quality of Life Innovation Technology 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP107-ATP107, February 1, 2025. Despite significant advancements, further research is essential to fully understand the mechanisms, optimize treatments, and fully harness the regenerative capabilities of stem cells, paving the way for innovative treatments that offer renewed hope for stroke patients.

Quality of Life 40

Quality of Life Strokes Stroke Innovation 40

DAIC

MARCH 25, 2025

tim.hodson Tue, 03/25/2025 - 16:19 March 25, 2025 Bayer plans to present data from 13 new analyses from across the KERENDIA (finerenone) comprehensive clinical trial program at the American College of Cardiology (ACC) 74 th Annual Scientific Session & Expo 2025 , in Chicago, IL, March 29-31, 2025. Bayer Pharmaceuticals.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Kidney Disease Research 52